Table 2

Clinical characteristics of women according to weekly alcohol intake

Alcohol intake, drinks* per week
All womenAbstainer<77–1314–20>20
Subjects, n110845601229110123
Drinks per week (median, (10%; 90%))5.6 (0.7–21.7)N/A2.3 (0.6–6.2)9.3 (7.4–12.2)18.8 (15.0–20.2)26.5 (21.7–40.9)
Years of follow-up (median (10%; 90%))4.7 (1.0–10.8)4.2 (1.1–11.4)4.8 (1.0–11.0)4.9 (0.9–11.0)5.3 (1.4–10.5)3.1 (0.7–9.5)
Age, years (median (10%; 90%))67.8 (60.2–74.6)68.7 (61.4–73.6)67.8 (59.6–74.5)67.2 (60.3–75.1)68.2 (60.5–74.2)68.9 (60.2–74.6)
 Age ≥75 years9.18.98.710.57.310.6
 Age 65–74 years59.457.859.956.360.961.8
Heart failure5.68.98.83.15.51.6
Hypertension28.033.329.623.625.528.5
Diabetes11.426.712.19.63.612.2
Previous
 Ischaemic stroke6.06.75.57.95.54.9
 TIA3.68.94.01.32.74.9
 Arterial thromboembolism0.40.00.21.30.90.0
Haemorrhagic stroke1.40.01.71.70.90.0
Vascular disease:
 Previous MI6.54.48.05.27.31.6
 Aortic plaque0.52.20.50.00.00.8
 Peripheral artery disease2.72.23.01.33.63.3
VKA treated14.46.715.510.014.520.3
CHADS2 (mean)0.811.160.820.790.640.78
 050.837.851.152.054.548.8
 129.031.127.029.733.632.5
 ≥220.231.122.018.311.818.7
CHA2DS2-VASc=121.317.821.122.720.921.1
  • Data are percentages unless otherwise stated.

  • *One drink corresponds to 12 g of pure alcohol.

  • MI, myocardial infarction; TIA, transient ischaemic attack; VKA, vitamin K antagonist